AlloVir (ALVR)
(Delayed Data from NSDQ)
$0.80 USD
0.00 (-0.36%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.80 0.00 (0.36%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for AlloVir, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 184 | 234 | 248 | 356 | 126 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 3 | 9 | 5 | 5 | 1 |
Total Current Assets | 188 | 243 | 253 | 361 | 127 |
Net Property & Equipment | 0 | 1 | 2 | 1 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 2 | 0 | 0 |
Total Assets | 191 | 277 | 287 | 371 | 139 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 3 | 8 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 10 | 14 | 20 | 8 | 5 |
Income Taxes Payable | 0 | 0 | 1 | 0 | 0 |
Other Current Liabilities | 1 | 0 | 2 | 1 | 0 |
Total Current Liabilities | 28 | 24 | 38 | 12 | 9 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 173 |
Total Liabilities | 45 | 53 | 61 | 18 | 191 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 802 | 691 | 522 | 478 | 4 |
Retained Earnings | -656 | -466 | -297 | -125 | -55 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 146 | 225 | 225 | 353 | -52 |
Total Liabilities & Shareholder's Equity | 191 | 277 | 287 | 371 | 139 |
Total Common Equity | 146 | 225 | 225 | 353 | -52 |
Shares Outstanding | 114.10 | 93.10 | 65.10 | 65.10 | NA |
Book Value Per Share | 1.28 | 2.41 | 3.46 | 5.42 | 0.00 |
Fiscal Year End for AlloVir, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 184 | 213 | 247 | 203 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 3 | 6 | 6 | 9 |
Total Current Assets | NA | 188 | 220 | 253 | 212 |
Net Property & Equipment | NA | 0 | 1 | 1 | 1 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 1 | 2 | 2 | 1 |
Total Assets | NA | 191 | 248 | 283 | 244 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 7 | 4 | 5 | 4 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 10 | 16 | 17 | 12 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 0 | 0 | 0 |
Total Current Liabilities | NA | 28 | 33 | 31 | 25 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 45 | 53 | 54 | 51 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 802 | 792 | 782 | 701 |
Retained Earnings | NA | -656 | -597 | -552 | -507 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 146 | 195 | 229 | 194 |
Total Liabilities & Shareholder's Equity | NA | 191 | 248 | 283 | 244 |
Total Common Equity | 0 | 146 | 195 | 229 | 194 |
Shares Outstanding | 114.80 | 114.10 | 114.00 | 113.80 | 93.50 |
Book Value Per Share | 0.00 | 1.28 | 1.71 | 2.01 | 2.07 |